Glenn Corbin
Optometrist · Wyomissing, PANPI 1508828666
Payments from drug & device makers
Across 657 payments — averaging $648.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$363K
- Maculogix, Inc.$36K
- Shire North American Group Inc$13K
- Alcon$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Coopervision Inc.$1K
- plus $5K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 441 | $363,479 |
| Maculogix, Inc. | 19 | $36,222 |
| Shire North American Group Inc | 9 | $13,082 |
| Alcon | 36 | $4,078 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,975 |
| Coopervision Inc. | 32 | $1,078 |
| Notal Vision, Inc. | 1 | $700 |
| AbbVie(2 entities) | 22 | $659 |
| Bausch & Lomb Americas Inc. | 17 | $451 |
| Sun Pharmaceutical Industries Inc. | 15 | $367 |
| LKC Technologies, Inc. | 4 | $345 |
| Tarsus Pharmaceuticals, Inc. | 6 | $284 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $276 |
| Oyster Point Pharma, Inc. | 8 | $219 |
| Rxsight Inc | 3 | $207 |
| Dompe US, Inc. | 3 | $177 |
| Glaukos Corporation | 2 | $156 |
| Novartis | 8 | $151 |
| Astellas Pharma Global Development | 1 | $150 |
| Amgen | 2 | $143 |
| Biotissue Holdings Inc. | 6 | $119 |
| Apellis Pharmaceuticals, Inc. | 1 | $110 |
| Ortho-clinical Diagnostics, Inc. | 1 | $101 |
| Johnson & Johnson Vision Care, Inc. | 3 | $84 |
| Quidel Corporation | 2 | $57 |
| Kala Pharmaceuticals, Inc. | 3 | $57 |
| ABB Con-cise Optical Group LLC | 1 | $35 |
| Astellas Pharma US Inc | 1 | $35 |
| Harrow Eye, LLC | 1 | $20 |
How this compares
$425,816 in reported general payments places this provider in the 95th percentile of 2,165 optometrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Wyomissing
- Amanda LeggeWyomissing$35K
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Leslie O DellNew Freedom$409K
- Kevin BistlinePlymouth Meeting$302K
- Thomas KislanStroudsburg$267K
- Erick HendersonPittsburgh$266K
- Natasha HindmanCranberry Twp$179K
- Ryan YealyLancaster$164K
- Michael CymborState College$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.